Entobel Holding Pte.
Latest round
- Series B
Last raised
- May 2022
Total raised
- $32M
Investors
- 4
About Entobel Holding Pte.
Based in Singapore and founded in 2013, Entobel Holding Pte. Ltd. is a biotech company that makes insect protein as a feed ingredient. Gaëtan Crielaard and Alexandre de Caters are the co-founders of the company. As of 2021, the company has more than 50 employees. The company develops the potential of the Black Soldier Fly—Hermetia illucens, an insect species well known for its bioconversion capacity and potential as a resource for various industries, including animal feed and animal health. Its insect-based products include H-Meal (used in animal feed formulations), H-Oil (potential applications in various industries), and H-Ferti (which encourages healthy soil for naturally lush plant growth). The company plans to use the series B funds received in January 2022 to finance the construction of a production facility in Vietnam.
Who invested in Entobel Holding Pte.
4 investors across 1 round
See all investors in Entobel Holding Pte.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
May 9, 2022
Amount
$32M
Investors
Questions about Entobel Holding Pte.
Who invested in Entobel Holding Pte.?
Entobel Holding Pte. has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Entobel Holding Pte. raised?
Entobel Holding Pte. has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Entobel Holding Pte. last raise money?
Entobel Holding Pte.'s most recent round on record is a Series B, in May 2022.
What does Entobel Holding Pte. do?
Based in Singapore and founded in 2013, Entobel Holding Pte.
Where is Entobel Holding Pte. headquartered?
Entobel Holding Pte. is headquartered in Singapore, Singapore.
Which VCs invest in companies like Entobel Holding Pte.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Entobel Holding Pte.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Entobel Holding Pte.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.